Diversified Healthcare Trust (NASDAQ:DHC) Announces Quarterly Earnings Results, Beats Estimates By $0.31 EPS

Diversified Healthcare Trust (NASDAQ:DHC) issued its quarterly earnings data on Tuesday. The real estate investment trust reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.31, Zacks reports. Diversified Healthcare Trust had a negative net margin of 26.09% and a negative return on equity of 17.55%.

Diversified Healthcare Trust Trading Up 1.7 %

Diversified Healthcare Trust stock opened at $2.45 on Wednesday. The stock has a 50-day moving average of $2.35 and a two-hundred day moving average of $2.91. The stock has a market cap of $591.12 million, a PE ratio of -1.52 and a beta of 2.17. The company has a debt-to-equity ratio of 1.44, a quick ratio of 11.57 and a current ratio of 11.57. Diversified Healthcare Trust has a one year low of $2.01 and a one year high of $4.24.

Diversified Healthcare Trust Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Monday, January 27th were given a $0.01 dividend. The ex-dividend date of this dividend was Monday, January 27th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.63%. Diversified Healthcare Trust’s payout ratio is -2.48%.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.